Back to Search
Start Over
Antidepressant effects of sulforaphane (SFN) and its derivatives SLL-III-9 and SLL-III-120 and their potential underlying mechanisms based on the microbiota-gut-brain axis.
- Source :
-
Food & function [Food Funct] 2024 Oct 14; Vol. 15 (20), pp. 10539-10552. Date of Electronic Publication: 2024 Oct 14. - Publication Year :
- 2024
-
Abstract
- Broccoli ( Brassica oleracea L.) is a vegetable with numerous nutritional properties, with sulforaphane (SFN) being the most abundant and unique bioactive ingredient. SFN has anti-inflammatory, antioxidant, and anti-cancer activities. In this study, a series of SFN derivatives were synthesized and screened for improved antidepressant effects. Among these, the SFN derivatives SLL-III-9 and SLL-III-120 were the best candidates, and the potential antidepressant mechanism of SFN, SLL-III-9, and SLL-III-120 associated with their effects in a chronic unpredictable mild stress (CUMS) mouse model was explored based on the microbiota-gut-brain axis. All three compounds were able to relieve depression-like behaviors in CUMS mice and regulate the composition of the gut bacteria Firmicutes, Actinobacteria, Parabasalia, and Tenericutes at the phylum level and Bacteroidales bacterium , Lachnospiraceae bacterium A4 , Muribaculum intestinale , Muribaculaceae bacterium , and Prevotella sp. MGM1 at the species level, possibly altering their function associated with the anti-inflammatory effect. Additionally, SFN and its derivatives upregulated the expression of the tight junction proteins ZO-1, occludin, and claudin and increased the concentration of IL-10, dopamine (DA), 5-hydroxytryptamine (5-HT) and the brain-derived neurotrophic factor (BDNF), while downregulating the expressions of proteins related to the NF-κB/NLRP3 pathway and reducing the concentration of TNF-α. Further in vitro studies revealed significant inhibition of the production of inflammatory factors IL-1β, IL-18, IL-6, and TNF-α in LPS-activated BV2 cells via the NF-κB/NLRP3 pathway when these cells were treated with SFN or its two derivatives. Taken together, the results suggested that SFN and its two derivatives, SLL-III-9 and SLL-III-120, could be considered potential compounds for the development of a promising and safe agent for combating depression.
- Subjects :
- Animals
Mice
Male
Brain-Gut Axis drug effects
Depression drug therapy
Mice, Inbred C57BL
Brassica chemistry
Disease Models, Animal
Brain drug effects
Brain metabolism
NF-kappa B metabolism
Sulfoxides pharmacology
Isothiocyanates pharmacology
Antidepressive Agents pharmacology
Gastrointestinal Microbiome drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 2042-650X
- Volume :
- 15
- Issue :
- 20
- Database :
- MEDLINE
- Journal :
- Food & function
- Publication Type :
- Academic Journal
- Accession number :
- 39370907
- Full Text :
- https://doi.org/10.1039/d3fo05278h